BluePath Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Buy
9,124
+907
+11% +$164K 0.73% 39
2026
Q1
$1.21M Buy
8,217
+1,492
+22% +$243K 0.83% 35
2025
Q4
$1.31M Buy
6,725
+1,387
+26% +$330K 0.88% 30
2025
Q3
$1.5M Buy
5,338
+456
+9% +$116K 1.1% 23
2025
Q2
$1.07M Sell
4,882
-158
-3% -$25.5K 0.94% 26
2025
Q1
$705K Sell
5,040
-1,713
-25% -$279K 0.73% 45
2024
Q4
$1.04M Buy
6,753
+216
+3% +$38.4K 0.56% 45
2024
Q3
$1.11M Buy
6,537
+770
+13% +$112K 0.69% 24
2024
Q2
$814K Buy
+5,767
New +$716K 0.57% 41
2023
Q4
Sell
-425
Closed -$45K 259
2023
Q3
$45K Buy
+425
New +$49.2K 0.04% 192

Other funds holding ORCL

BluePath Capital Management's ORCL Position: Q2 2026 in Review

BluePath Capital Management increased its Oracle (ORCL) stake by 11% in Q2 2026, buying an estimated $164K and bringing the position to 9,124 shares worth $1.34M. The position accounts for 0.73% of the portfolio, ranked #39.

BluePath Capital Management first reported a position in ORCL in Q3 2023 and has held it in 10 quarters since. The position peaked at $1.5M in Q3 2025. 1,158 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • BluePath Capital Management held 9,124 shares of Oracle worth $1.34M as of Q2 2026.
  • BluePath Capital Management bought 907 Oracle shares in Q2 2026, an estimated $164K.
  • Oracle made up 0.73% of BluePath Capital Management's portfolio in Q2 2026, its #39 holding.
  • BluePath Capital Management first reported a position in Oracle in Q3 2023 and has held it in 10 quarters since.
  • BluePath Capital Management's Oracle position peaked at $1.5M in Q3 2025.
  • 1,158 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.